Jnana Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States51-200 Employees

Jnana Therapeutics is a clinical-stage biotechnology company based in Boston, Massachusetts, focused on discovering medicines for highly validated but challenging-to-drug targets. It employs a next-generation chemoproteomics approach to identify druggable sites and guide development of therapies with the potential to address unmet medical needs. Its lead program is an oral candidate that targets an allosteric site on the phenylalanine transporter SLC6A19 for phenylketonuria, a rare genetic metabolic disorder. 

Jnana pursues treatments for diseases with high unmet need, including rare and immune-mediated conditions, within the biotechnology research landscape. In August 2024, the company disclosed a collaboration with Otsuka Pharmaceutical, illustrating ongoing industry partnerships to advance its programs.

Sign up for free to view info

Company overview Employee directory